| Literature DB >> 2415195 |
Abstract
Assay of breast cancers for oestrogen receptors helps to select advanced cases (about 30%) who will benefit from milder (endocrine) therapy, and, in early disease, gauge overall survival and likelihood of benefit from adjuvant endocrine therapy. A reliable immunocytochemical assay for receptor, now available, should extend the usefulness of such measurements.Entities:
Mesh:
Substances:
Year: 1985 PMID: 2415195
Source DB: PubMed Journal: Br J Hosp Med ISSN: 0007-1064